Allison White, APRN
Women's Health · Lincoln, NENPI 1093374332
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Astellas Pharma US Inc at 27.9% of the total. 2025 is the largest year on record at $1,030, more than ten times the $98 reported in 2021. Among women's health clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$842
- Mayne Pharma Commercial LLC$354
- Biogen$299
- Sumitomo Pharma America, Inc.$233
- Organon$199
- Exeltis, USA Inc.$196
- plus $897 from 17 others
What the payments were for
- Food & beverage$2,92697%
- Education$943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 24 | $842 |
| Mayne Pharma Commercial LLC | 40 | $354 |
| Biogen | 14 | $299 |
| Sumitomo Pharma America, Inc. | 13 | $233 |
| Organon | 10 | $199 |
| Exeltis, USA Inc. | 12 | $196 |
| AbbVie | 10 | $192 |
| Daiichi Sankyo Inc. | 8 | $124 |
| Myovant Sciences Inc. | 8 | $120 |
| Bayer | 5 | $94 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $74 |
| Coopersurgical, Inc. | 4 | $67 |
| Pfizer | 3 | $41 |
| Therapeuticsmd, Inc. | 2 | $31 |
| Baxter Healthcare | 1 | $31 |
| Merck | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Medtronic | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Scynexis, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Pharmacosmos Therapeutics Inc. | 1 | $13 |
How this compares
$3,020 in reported general payments places this provider in the 90th percentile of 60 women's health providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 23 | $1,362 |
Paid to pharmacies, not to this prescriber.
Other women's health in Lincoln
- Terra VejraskaLincoln$3K
- Jackie OdenLincoln$3K
- Audrey GrayLincoln$2K
- Jodi WegnerLincoln$2K
- Elizabeth HanselingLincoln$2K
- Lindsey MaasLincoln$1K
- Kathleen HunleyLincoln$1K
- Paula RailsbackLincoln$1K
- Mary SnowLincoln$944
- Emilie LongLincoln$937
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.